A literature review and clinical consensus guidelines on the management of Bullous Pemphigoid
- Author:
Clarisse G. Mendoza
1
;
Josef Symon S. Concha
2
;
Cybill Dianne C. Uy
3
;
Bryan K. Guevara
4
;
Evelyn R. Gonzaga
5
;
Maria Jasmin J. Jamora
6
;
Jamaine L. Cruz‑Regalado
7
;
Katrina C. Estrella
8
;
Melanie Joy D. Ruiz
9
;
Rogelio A. Balagat
10
;
Mae N. Ramirez‑Quizon
2
;
Johanna Pauline L. Dizon
11
;
Marie Eleanore O. Nicolas
12
Author Information
- Publication Type:Journal Article
- Keywords: Clinical consensus guidelines; Literature review
- MeSH: Pemphigoid, Bullous
- From: Journal of the Philippine Dermatological Society 2023;32(2):63-76
- CountryPhilippines
- Language:English
- Abstract: Bullous pemphigoid (BP) is the most common autoimmune blistering disease primarily characterized by tense blisters and occasionally with urticarial plaques, affecting the skin and mucous membranes. These are caused by autoantibodies against BP180 and BP230 which target antigens on the basement membrane zone. The diagnosis relies on the integration of clinical, histopathological, immunopathological, and serological findings. The management depends on the clinical extent and severity. We present in this article a literature review and the clinical consensus guidelines of the Immunodermatology Subspecialty Core Group of the Philippine Dermatological Society in the management of BP.
- Full text:a_literature_review_and_clinical_consensus.1.pdf
